Crucially, the presence of this signature (7.5-88% of the overall SNVs) in CD4+ cells isolated from the blood of SS patients suggests that these malignant T-cells either circulate freely from the skin to the blood compartment or develop from skin resident memory T-cells. The gene discussed is CD4; the disease is synovial sarcoma.